Moreover, the identified TCNEs exhibited significant differences in transcription levels in a public cohort (PRJNA739366) containing both NAT and breast cancer (p=4.96×10−15, Wilcoxon signed-rank test, Supplementary Figure S2L). This evidence concerns the gene BRD2 and breast cancer.